Product NDC: | 65162-212 |
Proprietary Name: | Extended Phenytoin Sodium |
Non Proprietary Name: | Phenytoin Sodium |
Active Ingredient(s): | 100 mg/1 & nbsp; Phenytoin Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65162-212 |
Labeler Name: | Amneal Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040765 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091216 |
Package NDC: | 65162-212-11 |
Package Description: | 1000 CAPSULE in 1 BOTTLE (65162-212-11) |
NDC Code | 65162-212-11 |
Proprietary Name | Extended Phenytoin Sodium |
Package Description | 1000 CAPSULE in 1 BOTTLE (65162-212-11) |
Product NDC | 65162-212 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Phenytoin Sodium |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20091216 |
Marketing Category Name | ANDA |
Labeler Name | Amneal Pharmaceuticals, LLC |
Substance Name | PHENYTOIN SODIUM |
Strength Number | 100 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |